SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-19-020183
Filing Date
2019-11-08
Accepted
2019-11-08 16:06:04
Documents
64
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 1284775
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 12143
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 12215
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6090
11 image00007.jpg GRAPHIC 44679
  Complete submission text file 0001140361-19-020183.txt   5366624

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rckt-20190930.xml EX-101.INS 879283
6 XBRL TAXONOMY EXTENSION SCHEMA rckt-20190930.xsd EX-101.SCH 45194
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20190930_cal.xml EX-101.CAL 56903
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20190930_def.xml EX-101.DEF 233107
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20190930_lab.xml EX-101.LAB 667452
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20190930_pre.xml EX-101.PRE 355934
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 191204078
SIC: 2834 Pharmaceutical Preparations